News & Insights
Blumberg Capital portfolio news, startup growth resources and industry insights
As brokers search for ways to reduce healthcare costs for employers, some of the focus has shifted toward transparency in drug pricing. Large employers including Amazon, Berkshire Hathaway and JPMorgan Chase took matters into their own hands when they launched their own joint healthcare venture, called Haven, in March.
But what do big changes like Haven mean for pharmacy benefit managers? Employee Benefit Adviser sat down with Jake Frenz, founder and CEO of the PBM SmithRx, to discuss the need for transparency in the PBM space, what Amazon’s new healthcare venture will mean and whether tactics like reference-based pricing will work.